Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Machold, KP; Kiener, HP; Graninger, W; Graninger, WB.
Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus.
Clin Immunol Immunopathol. 1993; 68(1): 74-78. Doi: 10.1006/clin.1993.1098
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Graninger Winfried
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Serum levels of the soluble form of the intercellular adhesion molecule-1 (sICAM-1) have been advocated as a parameter of clinical relevance in determining the activation of the immune system in inflammatory disease(s). We have determined sICAM-1 levels in 46 patients with rheumatoid arthritis (RA), in 53 patients with systemic lupus erythematosus (SLE), and in 82 healthy controls using a commercially available ELISA system. When compared to the healthy controls, sICAM-1 levels of the patients did not differ statistically significantly nor was there any difference between the patient groups. However, there was a strong correlation within the patient groups between sICAM-1 levels and conventional measures of disease activity. Thus, although sICAM-1 may be of theoretical interest with regard to immune activation, our results do not support the view of sICAM-1 providing additional information to the clinical rheumatologist when it is compared to more conventional measures such as acute-phase proteins or clinical activity scores.
Find related publications in this database (using NLM MeSH Indexing)
Adult -
Aged -
Arthritis, Rheumatoid - blood
Cell Adhesion Molecules - blood
Diagnosis-Related Groups -
Female -
Humans -
Intercellular Adhesion Molecule-1 -
Longitudinal Studies -
Lupus Erythematosus, Systemic - blood
Male -
Middle Aged -
Reference Values -
Severity of Illness Index -
Solubility -

© Med Uni Graz Impressum